Brief: Korea United Pharm signs contract worth 69.71 bln won
Oct 2(Reuters) - Korea United Pharm Inc 033270.KS :
* Says it signs 69.71 billion won contract to provide
anticancer
drug
Source text in Korean: https://bit.ly/2Osly9W
Further company coverage: 033270.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: Yinglan.Ma.reuters.com@reuters.net))
Recent news on Korea United Pharm
See all newsBrief: Korea United Pharm To Divest 9.4 Billion Won Worth Of Own Shares
Brief: Korea United Pharm To Divest 19 Billion Won Worth Of Own Shares
Brief: Korea United Pharm Q3 Operating Profit 12.5 Billion Won, Down 17% From Year Earlier
Brief: Korea United Pharm Q2 Operating Profit 10.8 Billion Won, Down 14% From Year Earlier
Brief: Korea United Pharm Q1 Operating Profit 13.8 Billion Won, Down 18.3% From Year Earlier